BiotechTube
Home/Mogling Bio/Yi Zheng
YZ

Yi Zheng

Co-founder, Cdc42/CASIN Expert

Mogling Bio

Therapeutic Areas

AgingMusculoskeletalImmunologyNeurologyHematology

Mogling Bio Pipeline

DrugIndicationPhase
Cdc42 Inhibition Platform (CASIN)Multiple age-related diseases (e.g., Osteoporosis, Immunosenescence, Neurodegeneration)Pre-clinical

Leadership Team at Mogling Bio

JR
Jürgen Reeß
Co-founder
HG
Hartmut Geiger
Co-founder, Stem Cell Aging and Rejuvenation Expert
AE
Anne Eldrup
Chief Development Officer (CDO)
TT
Tim Tracy
Chief Scientific Officer (CSO)
NH
Norbert Hauel
Medicinal Chemistry Expert
View full Mogling Bio profile